134 related articles for article (PubMed ID: 15554555)
21. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
22. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
23. Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 gene's polymorphisms in relation with ovarian cancer in a Romanian population.
Matei MC; Negură L; Liliac L; Negură A; Azoicăi D
Rom J Morphol Embryol; 2012; 53(1):47-54. PubMed ID: 22395499
[TBL] [Abstract][Full Text] [Related]
24. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
25. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women.
Malisic EJ; Jankovic RN; Jakovljevic KV; Radulovic SS
Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):90-3. PubMed ID: 23092908
[TBL] [Abstract][Full Text] [Related]
26. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.
Andersson S; Rylander E; Strand A; Sällström J; Wilander E
Br J Cancer; 2001 Oct; 85(8):1153-6. PubMed ID: 11710828
[TBL] [Abstract][Full Text] [Related]
27. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
[TBL] [Abstract][Full Text] [Related]
28. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis.
Lin X; Hou D; Huang C; Luo X
Arch Gynecol Obstet; 2016 Aug; 294(2):353-9. PubMed ID: 26749437
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?
Bastiaens MT; Struyk L; Tjong-A-Hung SP; Gruis N; ter Huurne J; Westendorp RG; Vermeer BJ; Bavinck JN; ter Schegget J
Mol Carcinog; 2001 Jan; 30(1):56-61. PubMed ID: 11255264
[TBL] [Abstract][Full Text] [Related]
30. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India.
Jain N; Singh V; Hedau S; Kumar S; Daga MK; Dewan R; Murthy NS; Husain SA; Das BC
Chest; 2005 Dec; 128(6):3999-4007. PubMed ID: 16354872
[TBL] [Abstract][Full Text] [Related]
31. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
32. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece.
Kalemi TG; Lambropoulos AF; Gueorguiev M; Chrisafi S; Papazisis KT; Kotsis A
Cancer Lett; 2005 May; 222(1):57-65. PubMed ID: 15837541
[TBL] [Abstract][Full Text] [Related]
33. WAF1 genotype and endometrial cancer susceptibility.
Hachiya T; Kuriaki Y; Ueoka Y; Nishida J; Kato K; Wake N
Gynecol Oncol; 1999 Feb; 72(2):187-92. PubMed ID: 10021299
[TBL] [Abstract][Full Text] [Related]
34. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1 polymorphism and risk of gynecological malignancy in Japan.
Sugawara T; Nomura E; Sagawa T; Sakuragi N; Fujimoto S
Int J Gynecol Cancer; 2003; 13(6):785-90. PubMed ID: 14675315
[TBL] [Abstract][Full Text] [Related]
36. [Study on the relationship between cervical cancer and p53 codon 72 polymorphism].
Qie M; Zhang Y; Wu J
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):274-5. PubMed ID: 12575207
[TBL] [Abstract][Full Text] [Related]
37. p53 codon 72 polymorphism and risk of cervical cancer in UK.
Rosenthal AN; Ryan A; Al-Jehani RM; Storey A; Harwood CA; Jacobs IJ
Lancet; 1998 Sep; 352(9131):871-2. PubMed ID: 9742979
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.
Gu Y; Zhou X; Zhang SL
Genet Mol Res; 2011 Oct; 10(4):3609-19. PubMed ID: 22057999
[TBL] [Abstract][Full Text] [Related]
39. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
[TBL] [Abstract][Full Text] [Related]
40. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
